Janne Mannila

发表

Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.

K. Järvinen, S. Auriola, Jukka Holappa, 2009, International journal of pharmaceutics.

Pharmacokinetics of intra-articular vitamin D analogue calcipotriol in sheep and metabolism in human synovial and mesenchymal stromal cells

U. Bergmann, T. Lassila, P. Lehenkari, 2019, The Journal of Steroid Biochemistry and Molecular Biology.

Fast‐dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits

K. Järvinen, J. Ketolainen, T. Järvinen, 2011, The Journal of pharmacy and pharmacology.

3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.

David M. Shackleford, K. Chibale, M. Witty, 2012, Journal of medicinal chemistry.

Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.

J. Chollet, S. Charman, E. Ryan, 2013, Journal of medicinal chemistry.

Effects of RM-β-CD on sublingual bioavailability of Δ9-tetrahydrocannabinol in rabbits

K. Järvinen, T. Järvinen, P. Jarho, 2005 .

Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.

K. Järvinen, P. Jarho, Janne Mannila, 2007, Journal of pharmaceutical sciences.

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase

David M. Shackleford, G. Drewes, M. Bantscheff, 2017, Science Translational Medicine.

Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.

K. Järvinen, P. Jarho, Jussi Tervonen, 2006, Life sciences.

Analysis of the Bile Acid Composition in a Fibroblast Growth Factor 19-Expressing Liver-Humanized Mouse Model and Its Use for CYP3A4-Mediated Drug–Drug Interaction Studies

M. Mezler, N. Scheer, A. Heikkinen, 2023, Drug Metabolism and Disposition.